Ragy Girgis

Director, The Center of Prevention and Evaluation (COPE), New York State Psychiatric Institute · New York Presbyterian Hospital

Credentials: · · ·

History

The Center of Prevention and Evaluation (COPE) · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Longitudinal Pet Imaging Of Antipsychotic Binding To The Dopamine-3 Receptor In Schizophrenia
National Institute of Mental Health · R01
Contact PI · $843.3K · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2026–2030
A Multimodal Imaging Study of Dopamine in Early Psychosis
National Institute of Mental Health · R01
Contact PI · $2.1M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2022–2029
1/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial
National Institute of Mental Health · R01
Contact PI · $5.2M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2021–2028
The Neurobiology of Violence in a Psychosis-Risk Cohort
National Institute of Mental Health · R01
Contact PI · $3.2M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2017–2026

A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Principal investigator · Recruiting · Phase 1, Phase 2
New York State Psychiatric Institute
2026–2027
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Principal investigator · Recruiting · Phase 4
New York State Psychiatric Institute
2022–2028
Gabapentin in Patients at Clinical Risk for Psychosis
Principal investigator · Terminated · Phase 1, Phase 2
New York State Psychiatric Institute
2015–2016
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Principal investigator · Completed · Phase 4
New York State Psychiatric Institute
2014–2017